BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 3286309)

  • 1. Lack of type VII collagen in unaffected skin of patients with severe recessive dystrophic epidermolysis bullosa.
    Bruckner-Tuderman L; Rüegger S; Odermatt B; Mitsuhashi Y; Schnyder UW
    Dermatologica; 1988; 176(2):57-64. PubMed ID: 3286309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermolysis bullosa dystrophica inversa in a child.
    Bruckner-Tuderman L; Pfaltz M; Schnyder UW
    Pediatr Dermatol; 1990 Jun; 7(2):116-21. PubMed ID: 2193305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type VII collagen is expressed but anchoring fibrils are defective in dystrophic epidermolysis bullosa inversa.
    Bruckner-Tuderman L; Niemi KM; Kero M; Schnyder UW; Reunala T
    Br J Dermatol; 1990 Mar; 122(3):383-90. PubMed ID: 2182097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermolysis bullosa simplex: identification of a kindred with autosomal recessive transmission of the Weber-Cockayne variety.
    Fine JD; Johnson L; Wright T; Horiguchi Y
    Pediatr Dermatol; 1989 Mar; 6(1):1-5. PubMed ID: 2539587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural variations in anchoring fibrils in dystrophic epidermolysis bullosa: correlation with type VII collagen expression.
    McGrath JA; Ishida-Yamamoto A; O'Grady A; Leigh IM; Eady RA
    J Invest Dermatol; 1993 Apr; 100(4):366-72. PubMed ID: 8454899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generalized atrophic benign epidermolysis bullosa. Either 180-kd bullous pemphigoid antigen or laminin-5 deficiency.
    Jonkman MF; de Jong MC; Heeres K; Steijlen PM; Owaribe K; Küster W; Meurer M; Gedde-Dahl T; Sonnenberg A; Bruckner-Tuderman L
    Arch Dermatol; 1996 Feb; 132(2):145-50. PubMed ID: 8629821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anchoring fibrils and type VII collagen are absent from skin in severe recessive dystrophic epidermolysis bullosa.
    Bruckner-Tuderman L; Mitsuhashi Y; Schnyder UW; Bruckner P
    J Invest Dermatol; 1989 Jul; 93(1):3-9. PubMed ID: 2746005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three new cases of transient bullous dermolysis of the newborn.
    Hanson SG; Fine JD; Levy ML
    J Am Acad Dermatol; 1999 Mar; 40(3):471-6. PubMed ID: 10071321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hereditary bullous epidermolyses. Recent aspects of diagnosis and therapy].
    Krieg T; Schurig V; Braun-Falco O
    Hautarzt; 1986 Apr; 37(4):185-9. PubMed ID: 3009355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 97 kDa linear IgA bullous dermatosis antigen is not expressed in a patient with generalized atrophic benign epidermolysis bullosa with a novel homozygous G258X mutation in COL17A1.
    Shimizu H; Takizawa Y; Pulkkinen L; Zone JJ; Matsumoto K; Saida T; Uitto J; Nishikawa T
    J Invest Dermatol; 1998 Nov; 111(5):887-92. PubMed ID: 9804354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mosaic expression of uncein and 180-kDa bullous pemphigoid antigen in generalized atrophic benign epidermolysis bullosa.
    Matsumura Y; Horiguchi Y; Toda K; Fujii H; Kore-Eda S; Tachibana T; Ohta K; Okamoto H; Imamura S
    Br J Dermatol; 1997 May; 136(5):757-61. PubMed ID: 9205513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining target antigens in linear IgA disease using skin from subjects with inherited epidermolysis bullosa as a substrate for indirect immunofluorescence microscopy.
    Harman KE; Bhogal BS; Eady RA; McGrath JA; Black MM
    Br J Dermatol; 1999 Sep; 141(3):475-80. PubMed ID: 10583051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemidesmosomal variants of epidermolysis bullosa. Mutations in the alpha6beta4 integrin and the 180-kD bullous pemphigoid antigen/type XVII collagen genes.
    Pulkkinen L; Uitto J
    Exp Dermatol; 1998; 7(2-3):46-64. PubMed ID: 9583744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 180-kD bullous pemphigoid antigen (BP180) is deficient in generalized atrophic benign epidermolysis bullosa.
    Jonkman MF; de Jong MC; Heeres K; Pas HH; van der Meer JB; Owaribe K; Martinez de Velasco AM; Niessen CM; Sonnenberg A
    J Clin Invest; 1995 Mar; 95(3):1345-52. PubMed ID: 7883981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moderation of phenotypic severity in dystrophic and junctional forms of epidermolysis bullosa through in-frame skipping of exons containing non-sense or frameshift mutations.
    McGrath JA; Ashton GH; Mellerio JE; Salas-Alanis JC; Swensson O; McMillan JR; Eady RA
    J Invest Dermatol; 1999 Sep; 113(3):314-21. PubMed ID: 10469327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The carboxyl-terminal domain of type VII collagen is present at the basement membrane in recessive dystrophic epidermolysis bullosa.
    Rusenko KW; Gammon WR; Fine JD; Briggaman RA
    J Invest Dermatol; 1989 Apr; 92(4):623-7. PubMed ID: 2649597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Animal model for dermolytic mechanobullous disease: sheep with recessive dystrophic epidermolysis bullosa lack collagen VII.
    Bruckner-Tuderman L; Guscetti F; Ehrensperger F
    J Invest Dermatol; 1991 Apr; 96(4):452-8. PubMed ID: 2007783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diminished expression of the extracellular domain of bullous pemphigoid antigen 2 (BPAG2) in the epidermal basement membrane of patients with generalized atrophic benign epidermolysis bullosa.
    Pohla-Gubo G; Lazarova Z; Giudice GJ; Liebert M; Grassegger A; Hintner H; Yancey KB
    Exp Dermatol; 1995 Aug; 4(4 Pt 1):199-206. PubMed ID: 8535614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of immunohistochemistry in the diagnosis of the non-lethal forms of junctional epidermolysis bullosa.
    McGrath JA; Eady RA
    J Dermatol Sci; 1997 Jan; 14(1):68-75. PubMed ID: 9049810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies to bullous pemphigoid and epidermolysis bullosa acquisita antigens in an infant.
    Kawachi Y; Ikegami M; Hashimoto T; Matsumura K; Tanaka T; Otsuka F
    Br J Dermatol; 1996 Sep; 135(3):443-7. PubMed ID: 8949441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.